Zacks Research Issues Negative Forecast for Nutrien Earnings

Key Points

• Zacks Research cut Nutrien’s Q3 2026 EPS forecast to $0.78 from $0.92, while projecting full-year 2026 earnings of $4.71 per share.
• Nutrien’s latest quarterly results missed EPS expectations, reporting $2.61 versus the $2.70 consensus, though revenue rose 3.6% year over year to $10.81 billion.
• Despite mixed earnings estimates, analysts maintain a consensus “Moderate Buy” rating with an average price target of $81.58; Nutrien also declared a $0.55 quarterly dividend, yielding about 3.0% annually.

Nutrien Ltd. (NYSE:NTR - Free Report) - Equities research analysts at Zacks Research reduced their Q3 2026 earnings per share (EPS) estimates for Nutrien in a report issued on Friday, August 21st. Zacks Research analyst Team now forecasts that the company will earn $0.78 per share for the quarter, down from their previous forecast of $0.92. The consensus estimate for Nutrien's current full-year earnings is $4.95 per share. Zacks Research also issued estimates for Nutrien's Q4 2026 earnings at $0.99 EPS, FY2026 earnings at $4.71 EPS, Q1 2027 earnings at $0.65 EPS, Q2 2027 earnings at $1.66 EPS, Q3 2027 earnings at $0.93 EPS, Q4 2027 earnings at $1.14 EPS, FY2027 earnings at $4.38 EPS, Q1 2028 earnings at $0.63 EPS, Q2 2028 earnings at $1.48 EPS and FY2028 earnings at $4.23 EPS.

Other research analysts have also recently issued reports about the stock. Morgan Stanley reduced their target price on shares of Nutrien from $93.00 to $81.00 and set an "overweight" rating on the stock in a research report on Tuesday, July 7th. Scotia upgraded Nutrien from a "sector perform" rating to a "sector outperform" rating and set a $80.00 target price for the company in a research report on Tuesday, June 30th. Mizuho dropped their price objective on shares of Nutrien from $77.00 to $75.00 and set a "neutral" rating on the stock in a research note on Tuesday, July 14th. Bank of America raised Nutrien from a "neutral" rating to a "buy" rating and set a $82.00 target price on the stock in a research report on Thursday, April 30th. Finally, UBS Group reduced their target price on shares of Nutrien from $67.00 to $65.00 and set a "sell" rating for the company in a research note on Monday, May 11th. Seventeen analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $81.58.

Nutrien Trading Down 0.6%

Shares of NTR opened at $73.17 on Friday. The stock's 50-day moving average is $67.12 and its two-hundred day moving average is $70.54. The stock has a market cap of $35.00 billion, a PE ratio of 14.81, a P/E/G ratio of 0.74 and a beta of 0.61. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.39 and a quick ratio of 0.86. Nutrien has a 12 month low of $53.03 and a 12 month high of $85.36.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $2.61 EPS for the quarter, missing analysts' consensus estimates of $2.70 by ($0.09). Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The firm had revenue of $10.81 billion during the quarter, compared to analysts' expectations of $10.44 billion. During the same quarter last year, the business earned $2.65 earnings per share. The business's revenue for the quarter was up 3.6% compared to the same quarter last year.

Institutional Investors Weigh In On Nutrien

Institutional investors and hedge funds have recently modified their holdings of the stock. Wellington Management Group LLP increased its stake in Nutrien by 440.2% in the 4th quarter. Wellington Management Group LLP now owns 16,338,606 shares of the company's stock worth $1,008,713,000 after purchasing an additional 13,313,817 shares in the last quarter. Deutsche Bank AG acquired a new position in shares of Nutrien in the second quarter worth about $588,720,000. Norges Bank acquired a new position in shares of Nutrien in the fourth quarter worth about $412,635,000. The Manufacturers Life Insurance Company purchased a new position in shares of Nutrien in the second quarter worth approximately $375,178,000. Finally, Canada Pension Plan Investment Board acquired a new stake in shares of Nutrien during the second quarter valued at approximately $359,318,000. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 16th. Stockholders of record on Tuesday, September 29th will be paid a dividend of $0.55 per share. The ex-dividend date of this dividend is Tuesday, September 29th. This represents a $2.20 annualized dividend and a dividend yield of 3.0%. Nutrien's dividend payout ratio (DPR) is currently 44.53%.

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source